ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL
<p>Abstract</p> <p>Background</p> <p>Acquired radioresistance of cancer cells remains a fundamental barrier to attaining the maximal efficacy of radiotherapy for the treatment of breast cancer. Anti-apoptotic proteins, such as Bcl-2 and Bcl-xL, play an important role in...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-12-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://www.jeccr.com/content/31/1/102 |
id |
doaj-b5f18d3825f6402eb095e29f4ef10318 |
---|---|
record_format |
Article |
spelling |
doaj-b5f18d3825f6402eb095e29f4ef103182020-11-24T21:36:20ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662012-12-0131110210.1186/1756-9966-31-102ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xLLi Ji-YuLi Yu-YangJin WeiYang QingShao Zhi-MingTian Xing-Song<p>Abstract</p> <p>Background</p> <p>Acquired radioresistance of cancer cells remains a fundamental barrier to attaining the maximal efficacy of radiotherapy for the treatment of breast cancer. Anti-apoptotic proteins, such as Bcl-2 and Bcl-xL, play an important role in the radioresistance of cancer cells. In the present study, we aimed to determine if ABT-737, a BH3-only mimic, could reverse the acquired radioresistance of the breast cancer cell line MDA-MB-231R by targeting Bcl-2 and Bcl-xL.</p> <p>Methods</p> <p>The radiosensitivity of MDA-MB-231 and MDA-MB-231R cells was compared using colony formation assays. Reverse-transcription PCR and western blot were performed to detect the expression of Bcl-2 and Bcl-xL in the cancer cell lines. Annexin V flow cytometric analysis and caspase-3 colorimetric assay were used to evaluate apoptosis of the cancer cells. Cell viability was measured using the Cell Counting Kit-8. The animals used in this study were 4 to 6-week-old athymic female BALB/c nu/nu mice.</p> <p>Results</p> <p>The MDA-MB-231R cells were more radioresistant than the MDA-MB-231 cells, and Bcl-2 and Bcl-xL were overexpressed in the MDA-MB-231R cells. While ABT-737 was able to restore the radiosensitivity of the MDA-MB-231R cells <it>in vitro</it> and <it>in vivo</it> experiment, it was not able to enhance the radiosensitivity of the MDA-MB-231 cells. In addition, ABT-737 increased radiation-induced apoptosis in the MDA-MB-231R cells. Bcl-2 and Bcl-xL were down regulated in the MDA-MB-231R cells following treatment with ABT-737.</p> <p>Conclusions</p> <p>Targeting of the anti-apoptotic proteins Bcl-2 and Bcl-xL with ABT-737 may reverse the acquired radioresistance of MDA-MB-231R cells in vitro and in vivo. These findings suggest an attractive strategy for overcoming the acquired radioresistance of breast cancer cells.</p> http://www.jeccr.com/content/31/1/102ABT-737Breast cancerAcquired radioresistanceRadiationBcl-2Bcl-xL |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Li Ji-Yu Li Yu-Yang Jin Wei Yang Qing Shao Zhi-Ming Tian Xing-Song |
spellingShingle |
Li Ji-Yu Li Yu-Yang Jin Wei Yang Qing Shao Zhi-Ming Tian Xing-Song ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL Journal of Experimental & Clinical Cancer Research ABT-737 Breast cancer Acquired radioresistance Radiation Bcl-2 Bcl-xL |
author_facet |
Li Ji-Yu Li Yu-Yang Jin Wei Yang Qing Shao Zhi-Ming Tian Xing-Song |
author_sort |
Li Ji-Yu |
title |
ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL |
title_short |
ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL |
title_full |
ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL |
title_fullStr |
ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL |
title_full_unstemmed |
ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL |
title_sort |
abt-737 reverses the acquired radioresistance of breast cancer cells by targeting bcl-2 and bcl-xl |
publisher |
BMC |
series |
Journal of Experimental & Clinical Cancer Research |
issn |
1756-9966 |
publishDate |
2012-12-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Acquired radioresistance of cancer cells remains a fundamental barrier to attaining the maximal efficacy of radiotherapy for the treatment of breast cancer. Anti-apoptotic proteins, such as Bcl-2 and Bcl-xL, play an important role in the radioresistance of cancer cells. In the present study, we aimed to determine if ABT-737, a BH3-only mimic, could reverse the acquired radioresistance of the breast cancer cell line MDA-MB-231R by targeting Bcl-2 and Bcl-xL.</p> <p>Methods</p> <p>The radiosensitivity of MDA-MB-231 and MDA-MB-231R cells was compared using colony formation assays. Reverse-transcription PCR and western blot were performed to detect the expression of Bcl-2 and Bcl-xL in the cancer cell lines. Annexin V flow cytometric analysis and caspase-3 colorimetric assay were used to evaluate apoptosis of the cancer cells. Cell viability was measured using the Cell Counting Kit-8. The animals used in this study were 4 to 6-week-old athymic female BALB/c nu/nu mice.</p> <p>Results</p> <p>The MDA-MB-231R cells were more radioresistant than the MDA-MB-231 cells, and Bcl-2 and Bcl-xL were overexpressed in the MDA-MB-231R cells. While ABT-737 was able to restore the radiosensitivity of the MDA-MB-231R cells <it>in vitro</it> and <it>in vivo</it> experiment, it was not able to enhance the radiosensitivity of the MDA-MB-231 cells. In addition, ABT-737 increased radiation-induced apoptosis in the MDA-MB-231R cells. Bcl-2 and Bcl-xL were down regulated in the MDA-MB-231R cells following treatment with ABT-737.</p> <p>Conclusions</p> <p>Targeting of the anti-apoptotic proteins Bcl-2 and Bcl-xL with ABT-737 may reverse the acquired radioresistance of MDA-MB-231R cells in vitro and in vivo. These findings suggest an attractive strategy for overcoming the acquired radioresistance of breast cancer cells.</p> |
topic |
ABT-737 Breast cancer Acquired radioresistance Radiation Bcl-2 Bcl-xL |
url |
http://www.jeccr.com/content/31/1/102 |
work_keys_str_mv |
AT lijiyu abt737reversestheacquiredradioresistanceofbreastcancercellsbytargetingbcl2andbclxl AT liyuyang abt737reversestheacquiredradioresistanceofbreastcancercellsbytargetingbcl2andbclxl AT jinwei abt737reversestheacquiredradioresistanceofbreastcancercellsbytargetingbcl2andbclxl AT yangqing abt737reversestheacquiredradioresistanceofbreastcancercellsbytargetingbcl2andbclxl AT shaozhiming abt737reversestheacquiredradioresistanceofbreastcancercellsbytargetingbcl2andbclxl AT tianxingsong abt737reversestheacquiredradioresistanceofbreastcancercellsbytargetingbcl2andbclxl |
_version_ |
1725941637629083648 |